This fund aims to track the Nasdaq Biotechnology index, which covers Nasdaq listed companies primarily engaged in biomedical research to develop new treatments and cures for human disease.
Fund data (holdings, countries, and sectors) is sourced from the BlackRock website.Last modified: 19 April 2025.This information is indicative only and its accuracy or completeness is not guaranteed.